Alta Semper Capital completes acquisition of Allmed Group to expand blood purification and dialysis solutions
Acquiring Company
Alta Semper Capital
Acquired Company
Allmed Group
Description
Alta Semper Capital, a London-based private equity firm, has announced the acquisition of Allmed Group, a global producer of blood purification product solutions. Together, they aim to leverage their combined expertise to improve healthcare access for patients with chronic kidney disease and other conditions requiring extracorporeal blood treatment, with a focus on expanding production capacity, entering new markets, and providing affordable healthcare solutions in growth markets like Africa and Latin America.
Quick answer
Alta Semper Capital is acquiring Allmed Group, announced June 13, 2024. Alta Semper Capital is based in London, England, United Kingdom.
- How much did Alta Semper Capital pay for Allmed Group?
- The deal value was not disclosed.
- What does Alta Semper Capital do?
- Alta Semper Capital is a London-based private equity firm specializing in impact investments primarily in the healthcare sector across growth markets.
- Where are Alta Semper Capital and Allmed Group based?
- Alta Semper Capital is based in London, England, United Kingdom. Allmed Group is based in London, England, United Kingdom.
- Who are the decision-makers at Alta Semper Capital?
- Fundz holds 1 contact at Alta Semper Capital. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Venture Capital and Health Care
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Edwards Lifesciences Completes Acquisitions of JenaValve Technology and Endotronix (July 24, 2024)
- AA Medical completes acquisition of Surgical Product Solutions, forming strategic partnership (July 11, 2024)
- Novo Holdings A/S to acquire Catalent, Inc. for $63.50 per share in cash (May 29, 2024)
- Merck completes acquisition of EyeBio to diversify its late-stage pipeline (July 12, 2024)
- Revelation Pharma expands with acquisitions of Taylors Pharmacy and Key Compounding (July 9, 2024)
- Sudeep Pharma promoters regain 100% ownership by acquiring 50% shares from JRS Pharma (July 8, 2024)
Who to call at Alta Semper Capital, and when
When Alta Semper Capital changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Alta Semper Capital raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alta Semper Capital, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alta Semper Capital. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alta Semper Capital makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Allmed Group?
Allmed Group was acquired by Alta Semper Capital, based in London. The deal was reported on June 13, 2024. Alta Semper Capital is a London-based private equity firm specializing in impact investments primarily in the healthcare sector across growth markets. Alta Semper Capital is privately held and operates in Health Care.
When did Alta Semper Capital acquire Allmed Group?
Alta Semper Capital's acquisition of Allmed Group was reported on June 13, 2024. Alta Semper Capital, a London-based private equity firm, has announced the acquisition of Allmed Group, a global producer of blood purification product solutions. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Allmed Group do?
Allmed Group is a global producer of end-to-end blood purification and haemodialysis solutions, headquartered in London. It is privately held, operating in Manufacturing, and is based in London.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.